You can buy or sell OSIR and other stocks, options, ETFs, and crypto commission-free!
Osiris Therapeutics, Inc. engages in researching, developing, manufacturing and commercializing regenerative medicine products. It operates through Biosurgery segment which focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. Read More The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.
52 Week High
52 Week Low
Research And Development
Form SC TO-T OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC
-- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OSIRIS THERAPEUTICS, INC. (Name of Subject Company) PAPYRUS ACQUISITION CORP. (Offeror) SMITH & NEPHEW CONSOLIDATED, INC. SMITH & NEPHEW PLC (Parent of Offeror) (Names of Filing Persons) Common stock, par value $0.001 per share (Title of...
Yahoo FinanceMar 15
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Osiris Therapeutics, Inc. – OSIR
BALA CYNWYD, PA / ACCESSWIRE / March 15, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Osiris Therapeutics, Inc.
Expected Mar 27, After Hours